BridgeMD
New treatment option for Mononeuropathies
Official title Spinal Cord Stimulation for Intractable Mononeuropathy
ClinicalTrials.gov ID: NCT06546371
What this study is testing
- What it's testing
- Rationale: For patients with mononeuropathy, literature has shown that spinal cord stimulation (SCS) is an effective therapy for patients who are therapy-resistant to more conventional treatments. However, there is a strong need for higher quality evidence to determine the place of this therapy in this target group.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Suffering from painful intractable peripheral mononeuropathy in the distal extremities, preferably post-traumatic or post-surgical, confirmed by...
- Symptoms refractory to conventional medical management for at least 6 months according to treating physician
- 18 years or older
- Pain score on numeric rating scale (NRS) of at least 5 (average pain intensity in week prior to assessment)
- Stable or absent concomitant analgesics
You likely can't join if
- Mononeuropathy located in the head or torso
- Mononeuropathy by avulsion at the plexus brachialis
- Life expectancy \<1 year
- Anticoagulant drug therapy or disturbed coagulation
- Immune-compromised patients
- Pregnancy
See the full eligibility criteria
- Suffering from painful intractable peripheral mononeuropathy in the distal extremities, preferably post-traumatic or post-surgical, confirmed by electromyography (EMG)
- Symptoms refractory to conventional medical management for at least 6 months according to treating physician
- 18 years or older
- Pain score on numeric rating scale (NRS) of at least 5 (average pain intensity in week prior to assessment)
- Stable or absent concomitant analgesics
- Mononeuropathy located in the head or torso
- Mononeuropathy by avulsion at the plexus brachialis
- Life expectancy \<1 year
- Anticoagulant drug therapy or disturbed coagulation
- Immune-compromised patients
- Pregnancy
- Lack of cooperation of the patient or patient has a history of noncompliance with regard to (a) medical regime(s)
- Patients with psychological factors or addiction that require treatment
The study team makes the final eligibility decision.
Where it's taking place
- Rotterdam, South Holland, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rotterdam, South Holland, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.